AnaptysBio
ANAB
ANAB
113 hedge funds and large institutions have $675M invested in AnaptysBio in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
4.51% less ownership
Funds ownership: 115.64% → 111.13% (-4.5%)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
32% less capital invested
Capital invested by funds: $990M → $675M (-$314M)
Holders
113
Holding in Top 10
2
Calls
$1.47M
Puts
$1.34M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$5.37M | |
| 3 | +$3.47M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$2.51M |
| 5 |
Goldman Sachs
New York
|
+$1.7M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$13M | |
| 3 | -$11.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.64M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.75M |